SCHEMBL3142829

SCHEMBL3142829

Cc1ccc2[nH]c3ccc(C(c4ccc(N(C)C)cc4)c4ccc5[nH]c6ccccc6c5c4)cc3c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 6/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
NPC1 O15118 1/20 0.48
POLB P06746 1/20 0.48
VDR P11473 2/20 0.47
MLKL Q8NB16 1/20 0.42
AHR P35869 1/20 0.40
CNR1 P21554 1/20 0.40
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40
GABRA2 P47869 1/20 0.40
GABRB2 P47870 1/20 0.40
GABRA4 P48169 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10358233 0.82 KIF11 (0.45) KIF11MEN1KMT2APOLBVDR
SCHEMBL28363827 0.81 AHR (0.59) KIF11MEN1KMT2APOLBAHR
SCHEMBL10114729 0.80 MLKL (0.46) KIF11MEN1KMT2ANPC1POLB
SCHEMBL10114753 0.79 MLKL (0.45) KIF11MEN1KMT2ANPC1POLB
SCHEMBL28201526 0.78 AHR (0.55) KIF11MEN1KMT2APOLBAHR
SCHEMBL262221 0.78 KIF11 (0.77) KIF11MEN1KMT2ANPC1POLB
Carbazole SCHEMBL28016320 0.78 KIF11 (0.77) KIF11MEN1KMT2ANPC1POLB
SCHEMBL29563317 0.78 KIF11 (0.77) KIF11MEN1KMT2ANPC1POLB
SCHEMBL11846487 0.76 AHR (0.57) KIF11MEN1KMT2AVDRAHR
SCHEMBL11798982 0.76 VDR (0.66) MEN1KMT2APOLBVDRAHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7217297-B2 Composition for dyeing keratin fibers comprising a defined diheteroylarylmethane direct dye or a leuco precursor of this dye and dyeing method using it L'OREAL S.A. (FR) 2007-05-15 US claimed
US-20040187229-A1 Composition for dyeing keratin fibers comprising a defined diheteroylarylmethane direct dye or a leuco precursor of this dye and dyeing method using it L'OREAL S.A. (FR) 2004-09-30 US claimed
EP-1437122-A1 Composition for dyeing keratinic fibers comprising a diheteroarylmethane direct dye or its lecuco precursor and dyeing process using this composition L'OREAL (FR) 2004-07-14 EP claimed
EP-1437122-B1 Composition for dyeing keratinic fibers comprising diheteroarylmethane direct dye and dyeing process using this composition OREAL (FR) 2010-03-03 EP disclosed
US-7217297-B2 Composition for dyeing keratin fibers comprising a defined diheteroylarylmethane direct dye or a leuco precursor of this dye and dyeing method using it L'OREAL S.A. (FR) 2007-05-15 US disclosed
US-20040187229-A1 Composition for dyeing keratin fibers comprising a defined diheteroylarylmethane direct dye or a leuco precursor of this dye and dyeing method using it L'OREAL S.A. (FR) 2004-09-30 US disclosed
EP-1437122-A1 Composition for dyeing keratinic fibers comprising a diheteroarylmethane direct dye or its lecuco precursor and dyeing process using this composition L'OREAL (FR) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040187229-A1 Composition for dyeing keratin fibers comprising a defined diheteroylarylmethane direct dye or a leuco precursor of this dye and dyeing method using it KRT18, KMO, DLD KIF11 417/4885MEN1 4265/4885KMT2A 273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.